Over-the-counter medicine
Norgestrel Brand names: Opill, Daily
Norgestrel (Daily) is an over-the-counter medicine with an FDA approval on record since 1973. No generic is listed; pharmacies paid $0.549 per Opill 0.075 mg tablet in the October 7, 2026 NADAC survey.
- No generic listed
- Over the counter
Check it at the source: the norgestrel FDA label on DailyMed (effective August 6, 2026, CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED); the NDA 17031 record on Drugs@FDA; every norgestrel label on DailyMed.
Highlights of the record
FDA label of August 6, 2026; NDC Directory, Drugs@FDA and Orange Book, October 8, 2026; NADAC October 7, 2026
Used for
From the label: indications and usageTo prevent pregnancy
Forms and strengths
- 0.075 mg
Tablet.
On the market
- Earliest approval on file
- October 23, 1973 Opill, Laboratoire Hra; Drugs@FDA’s file, where older or withdrawn approvals can be missing
- Generic approvals
- No generic approved
- Labelers listed (NDC)
- 4 of which 0 under generic applications, 4 under brand applications, repackagers included
Supply and safety
- Pharmacy cost (NADAC)
- $0.549 per tablet Opill 0.075 mg tablet
- Shortage (FDA)
- No current entry
- Recalls by its makers (FDA)
- No recall recorded
- FAERS reports
- 1,350 through July 30, 2026
What is norgestrel used for?
From the label: indications and usageTo prevent pregnancy
Source: FDA drug label (Daily Oral Contraceptive), NDA017031 (Laboratoire Hra), as published by CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED, effective August 6, 2026 (SPL set 20477912-c1d6-4190-8f6e-00fb122134a1), via openFDA; the full label on DailyMed
Is there a generic for norgestrel (Daily)?
No generic norgestrel is approved (Drugs@FDA, October 8, 2026).
- 1973 earliest approval on file
Source: Drugs@FDA, FDA NDC Directory and the Orange Book (openFDA bulk files, October 8, 2026)
What do pharmacies pay for norgestrel (Daily)?
In CMS's NADAC survey of October 7, 2026, pharmacies paid $0.549 per Opill 0.075 mg tablet, about the same as a year earlier. The chart's scale runs from the lowest to the highest price shown, not from zero. NADAC is what retail pharmacies paid their wholesalers, per unit, in CMS's monthly survey; what a patient pays depends on insurance and the pharmacy.
- Opill 0.075 mg tablet (brand)
| Strength and form | Brand or generic | Pharmacy cost | 30 tablets, or one pen or vial | 12-month change |
|---|---|---|---|---|
| Opill 0.075 mg tablet | Brand | $0.549 per tablet | $16.46 | -0.4% |
Source: CMS National Average Drug Acquisition Cost (NADAC) survey, October 7, 2026: what retail pharmacies paid per unit; not a counter price
What does the norgestrel label say about other medicines?
The norgestrel label names 2 other medicines in its interaction, contraindication or warning sections. The labels of 4 other medicines name norgestrel. The sentences are the labels' own; a label lists what its studies and reports found, not every interaction.
| Medicine named | Section | What the label says |
|---|---|---|
| Aspirin | warnings | People allergic to aspirin often have a tartrazine allergy too. |
| Ulipristal | warnings | if you have taken ulipristal acetate (an emergency contraceptive, or morning after pill) in the past 5 days See the enclosed leaflet for a detailed list of medicines that may interact with this product. |
Other labels that name norgestrel
Source: FDA drug label (Daily Oral Contraceptive), NDA017031 (Laboratoire Hra), as published by CVS WOONSOCKET PRESCRIPTION CENTER, INCORPORATED, effective August 6, 2026 (SPL set 20477912-c1d6-4190-8f6e-00fb122134a1), via openFDA; the full label on DailyMed
What do FAERS reports show for norgestrel?
The FDA Adverse Event Reporting System holds 1,350 reports that list norgestrel among the medicines taken, through July 30, 2026, each a report of something that happened, not proof the medicine caused it; 1 are coded as a death and 23 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is.
Reports received each year
The most reported reactions
Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026
What next?
- Norgestrel side effects
- the label's list beside FAERS reports
- Check an interaction
- what two or more labels say about each other